In Vivo Analysis of Aicda Gene Regulation: A Critical Balance between Upstream Enhancers and Intronic Silencers Governs Appropriate Expression

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Huong, Le Thi ^a,d   Kobayashi, Maki ^a   Nakata, Mikiyo ^a   Shioi, Go ^c   Miyachi, Hitoshi ^a   Honjo, Tasuku ^a   Nagaoka, Hitoshi ^b  

^a KYOTO UNIVERSITY   (Japan)

^b GIFU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c RIKEN Center for Biosystems Dynamics Research   (Japan)

^d Thai Nguyen University of Medicine and Pharmacy   (Viet Nam)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATION INDUCED CYTIDINE DEAMINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN C MYB; SMAD PROTEIN; STAT6 PROTEIN; TRANSCRIPTION FACTOR E2F;

ACTIVATION INDUCED CYTIDINE DEAMINASE GENE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; BACTERIAL ARTIFICIAL CHROMOSOME; BINDING SITE; CONTROLLED STUDY; ENHANCER REGION; GENE CLUSTER; GENE DELETION; GENE EXPRESSION REGULATION; GENE FUNCTION; GERMINAL CENTER; IN VIVO STUDY; INTRON; MOUSE; MUTATIONAL ANALYSIS; NONHUMAN; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN MOTIF; SILENCER ELEMENT; T LYMPHOCYTE; TRANSCRIPTION INITIATION SITE;

ANIMALS; CHROMOSOMES, ARTIFICIAL, BACTERIAL; CYTIDINE DEAMINASE; ENHANCER ELEMENTS, GENETIC; GENE EXPRESSION REGULATION; INTRONS; MICE; MICE, TRANSGENIC; PROMOTER REGIONS, GENETIC; REGULATORY SEQUENCES, NUCLEIC ACID;

BACTERIA (MICROORGANISMS);

EID: 84876183774     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0061433     Document Type: Article

References (48)

1. Muramatsu M, Kinoshita K, Fagarasan S, Yamada S, Shinkai Y, et al. (2000) Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell 102: 553-563.
2. Revy P, Muto T, Levy Y, Geissmann F, Plebani A, et al. (2000) Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the Hyper-IgM syndrome (HIGM2). Cell 102: 565-575.
3. Nagaoka H, Muramatsu M, Yamamura N, Kinoshita K, Honjo T, (2002) Activation-induced deaminase (AID)-directed hypermutation in the immunoglobulin Smu region: implication of AID involvement in a common step of class switch recombination and somatic hypermutation. J Exp Med 195: 529-534.
4. Petersen S, Casellas R, Reina-San-Martin B, Chen HT, Difilippantonio MJ, et al. (2001) AID is required to initiate Nbs1/gamma-H2AX focus formation and mutations at sites of class switching. Nature 414: 660-665.
5. Liu M, Duke JL, Richter DJ, Vinuesa CG, Goodnow CC, et al. (2008) Two levels of protection for the B cell genome during somatic hypermutation. Nature 451: 841-845.
6. Kato L, Begum NA, Burroughs AM, Doi T, Kawai J, et al. (2012) Nonimmunoglobulin target loci of activation-induced cytidine deaminase (AID) share unique features with immunoglobulin genes. Proc Natl Acad Sci U S A 109: 2479-2484.
7. Kotani A, Okazaki IM, Muramatsu M, Kinoshita K, Begum NA, et al. (2005) A target selection of somatic hypermutations is regulated similarly between T and B cells upon activation-induced cytidine deaminase expression. Proc Natl Acad Sci U S A 102: 4506-4511.
8. Yamane A, Resch W, Kuo N, Kuchen S, Li Z, et al. (2011) Deep-sequencing identification of the genomic targets of the cytidine deaminase AID and its cofactor RPA in B lymphocytes. Nat Immunol 12: 62-69.
9. Pavri R, Gazumyan A, Jankovic M, Di Virgilio M, Klein I, et al. (2010) Activation-induced cytidine deaminase targets DNA at sites of RNA polymerase II stalling by interaction with Spt5. Cell 143: 122-133.
10. Honjo T, Kobayashi M, Begum N, Kotani A, Sabouri S, et al. (2012) The AID Dilemma: Infection, or Cancer? Adv Cancer Res 113: 1-44.
11. Okazaki IM, Hiai H, Kakazu N, Yamada S, Muramatsu M, et al. (2003) Constitutive expression of AID leads to tumorigenesis. J Exp Med 197: 1173-1181.
12. Takai A, Toyoshima T, Uemura M, Kitawaki Y, Marusawa H, et al. (2009) A novel mouse model of hepatocarcinogenesis triggered by AID causing deleterious p53 mutations. Oncogene 28: 469-478.
13. Ramiro AR, Jankovic M, Eisenreich T, Difilippantonio S, Chen-Kiang S, et al. (2004) AID is required for c-myc/IgH chromosome translocations in vivo. Cell 118: 431-438.
14. Takizawa M, Tolarova H, Li Z, Dubois W, Lim S, et al. (2008) AID expression levels determine the extent of cMyc oncogenic translocations and the incidence of B cell tumor development. J Exp Med 205: 1949-1957.
15. Muramatsu M, Sankaranand VS, Anant S, Sugai M, Kinoshita K, et al. (1999) Specific expression of activation-induced cytidine deaminase (AID), a novel member of the RNA-editing deaminase family in germinal center B cells. J Biol Chem 274: 18470-18476.
16. Crouch EE, Li Z, Takizawa M, Fichtner-Feigl S, Gourzi P, et al. (2007) Regulation of AID expression in the immune response. J Exp Med 204: 1145-1156.
17. Qin H, Suzuki K, Nakata M, Chikuma S, Izumi N, et al. (2011) Activation-Induced Cytidine Deaminase Expression in CD4 T Cells is Associated with a Unique IL-10-Producing Subset that Increases with Age. PLoS One 6: e29141.
18. Matsumoto Y, Marusawa H, Kinoshita K, Endo Y, Kou T, et al. (2007) Helicobacter pylori infection triggers aberrant expression of activation-induced cytidine deaminase in gastric epithelium. Nat Med 13: 470-476.
19. Epeldegui M, Hung YP, McQuay A, Ambinder RF, Martinez-Maza O, (2007) Infection of human B cells with Epstein-Barr virus results in the expression of somatic hypermutation-inducing molecules and in the accrual of oncogene mutations. Mol Immunol 44: 934-942.
20. Fan J, Ma G, Nosaka K, Tanabe J, Satou Y, et al. (2010) APOBEC3G generates nonsense mutations in human T-cell leukemia virus type 1 proviral genomes in vivo. J Virol 84: 7278-7287.
21. Machida K, Cheng KT, Sung VM, Shimodaira S, Lindsay KL, et al. (2004) Hepatitis C virus induces a mutator phenotype: enhanced mutations of immunoglobulin and protooncogenes. Proc Natl Acad Sci U S A 101: 4262-4267.
22. Ishikawa C, Nakachi S, Senba M, Sugai M, Mori N, (2011) Activation of AID by human T-cell leukemia virus Tax oncoprotein and the possible role of its constitutive expression in ATL genesis. Carcinogenesis 32: 110-119.
23. Mao C, Jiang L, Melo-Jorge M, Puthenveetil M, Zhang X, et al. (2004) T cell-independent somatic hypermutation in murine B cells with an immature phenotype. Immunity 20: 133-144.
24. Ueda Y, Liao D, Yang K, Patel A, Kelsoe G, (2007) T-independent activation-induced cytidine deaminase expression, class-switch recombination, and antibody production by immature/transitional 1 B cells. J Immunol 178: 3593-3601.
25. Kuraoka M, Holl TM, Liao D, Womble M, Cain DW, et al. (2011) Activation-induced cytidine deaminase mediates central tolerance in B cells. Proc Natl Acad Sci USA 108: 11560-11565.
26. Meyers G, Ng YS, Bannock JM, Lavoie A, Walter JE, et al. (2011) Activation-induced cytidine deaminase (AID) is required for B-cell tolerance in humans. Proc Natl Acad Sci U S A 108: 11554-11559.
27. Yadav A, Olaru A, Saltis M, Setren A, Cerny J, et al. (2006) Identification of a ubiquitously active promoter of the murine activation-induced cytidine deaminase (AICDA) gene. Mol Immunol 43: 529-541.
28. Tran TH, Nakata M, Suzuki K, Begum NA, Shinkura R, et al. (2010) B cell-specific and stimulation-responsive enhancers derepress Aicda by overcoming the effects of silencers. Nat Immunol 11: 148-154.
29. Park SR, Zan H, Pal Z, Zhang J, Al-Qahtani A, et al. (2009) HoxC4 binds to the promoter of the cytidine deaminase AID gene to induce AID expression, class-switch DNA recombination and somatic hypermutation. Nat Immunol 10: 540-550.
30. Park SR, Kim PH, Lee KS, Lee SH, Seo GY, et al. (2012) APRIL stimulates NF-kappaB-mediated HoxC4 induction for AID expression in mouse B cells. Cytokine.
31. Sayegh CE, Quong MW, Agata Y, Murre C, (2003) E-proteins directly regulate expression of activation-induced deaminase in mature B cells. Nat Immunol 4: 586-593.
32. Kwon K, Hutter C, Sun Q, Bilic I, Cobaleda C, et al. (2008) Instructive role of the transcription factor E2A in early B lymphopoiesis and germinal center B cell development. Immunity 28: 751-762.
33. Luche H, Weber O, Nageswara Rao T, Blum C, Fehling HJ, (2007) Faithful activation of an extra-bright red fluorescent protein in "knock-in" Cre-reporter mice ideally suited for lineage tracing studies. Eur J Immunol 37: 43-53.
34. Lalmanach-Girard AC, Chiles TC, Parker DC, Rothstein TL, (1993) T cell-dependent induction of NF-kappa B in B cells. J Exp Med 177: 1215-1219.
35. Takeda K, Kishimoto T, Akira S, (1997) STAT6: its role in interleukin 4-mediated biological functions. J Mol Med 75: 317-326.
36. Heldin CH, Miyazono K, ten Dijke P, (1997) TGF-beta signalling from cell membrane to nucleus through SMAD proteins. Nature 390: 465-471.
37. Fagarasan S, Muramatsu M, Suzuki K, Nagaoka H, Hiai H, et al. (2002) Critical roles of activation-induced cytidine deaminase in the homeostasis of gut flora. Science 298: 1424-1427.
38. Jacob J, Kassir R, Kelsoe G, (1991) In situ studies of the primary immune response to (4-hydroxy-3-nitrophenyl)acetyl. I. The architecture and dynamics of responding cell populations. J Exp Med 173: 1165-1175.
39. Takahashi Y, Ohta H, Takemori T, (2001) Fas is required for clonal selection in germinal centers and the subsequent establishment of the memory B cell repertoire. Immunity 14: 181-192.
40. Nagaoka H, Tran TH, Kobayashi M, Aida M, Honjo T, (2010) Preventing AID, a physiological mutator, from deleterious activation: regulation of the genomic instability that is associated with antibody diversity. Int Immunol 22: 227-235.
41. Gonda H, Sugai M, Nambu Y, Katakai T, Agata Y, et al. (2003) The balance between Pax5 and Id2 activities is the key to AID gene expression. J Exp Med 198: 1427-1437.
42. Frolov MV, Dyson NJ, (2004) Molecular mechanisms of E2F-dependent activation and pRB-mediated repression. J Cell Sci 117: 2173-2181.
43. Matsusaka T, Fujikawa K, Nishio Y, Mukaida N, Matsushima K, et al. (1993) Transcription factors NF-IL6 and NF-kappa B synergistically activate transcription of the inflammatory cytokines, interleukin 6 and interleukin 8. Proc Natl Acad Sci U S A 90: 10193-10197.
44. LeClair KP, Blanar MA, Sharp PA, (1992) The p50 subunit of NF-kappa B associates with the NF-IL6 transcription factor. Proc Natl Acad Sci U S A 89: 8145-8149.
45. Chen J, Zhao M, Rao R, Inoue H, Hao CM, (2005) C/EBP{beta} and its binding element are required for NF{kappa}B-induced COX2 expression following hypertonic stress. J Biol Chem 280: 16354-16359.
46. Takeuchi O, Akira S, (2010) Pattern recognition receptors and inflammation. Cell 140: 805-820.
47. Ramji DP, Foka P, (2002) CCAAT/enhancer-binding proteins: structure, function and regulation. Biochem J 365: 561-575.
48. Poli V, (1998) The role of C/EBP isoforms in the control of inflammatory and native immunity functions. J Biol Chem 273: 29279-29282.